CAMP4 Therapeutics Corporation – NASDAQ:CAMP
CAMP4 Therapeutics stock price today
$1.7
-3.72
-68.69%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 2 hours
CAMP4 Therapeutics stock price monthly change
+1772.41%
month
CAMP4 Therapeutics stock price quarterly change
+1772.41%
quarter
CAMP4 Therapeutics stock price yearly change
+2143.80%
year
CAMP4 Therapeutics key metrics
Market Cap | 110.88M |
Enterprise value | 312.50M |
P/E | -3.42 |
EV/Sales | 1.09 |
EV/EBITDA | -131.52 |
Price/Sales | 0.40 |
Price/Book | 6.18 |
PEG ratio | -0.06 |
EPS | -0.95 |
Revenue | 294.67M |
EBITDA | -545K |
Income | -34.13M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -11.79% |
Oper. margin | -8.46% |
Gross margin | 38.38% |
EBIT margin | -8.46% |
EBITDA margin | -0.18% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCAMP4 Therapeutics stock price history
CAMP4 Therapeutics stock forecast
CAMP4 Therapeutics financial statements
Average Price Target
$17.5
Potential upside: 929.41%
Analysts Price target
Financials & Ratios estimates
| Aug 2021 | 79.01M | -5.42M | -6.87% |
|---|---|---|---|
| Nov 2021 | 68.77M | -11.43M | -16.63% |
| Feb 2022 | 68.37M | -9.18M | -13.43% |
| Feb 2023 | 78.50M | -8.09M | -10.3% |
| May 2022 | 374793000 | 346.20M | 92.37% |
|---|---|---|---|
| Aug 2022 | 371038000 | 349.21M | 94.12% |
| Nov 2022 | 388906000 | 370.21M | 95.19% |
| Feb 2023 | 380120000 | 365.81M | 96.24% |
| Aug 2021 | 10.37M | -3.47M | -2.30M |
|---|---|---|---|
| Nov 2021 | -7.13M | -4.66M | -111K |
| Feb 2022 | -7.53M | -2.95M | 585K |
| Feb 2023 | -1.09M | -1.80M | 264K |
CAMP4 Therapeutics alternative data
| Aug 2023 | 644 |
|---|---|
| Sep 2023 | 644 |
| Oct 2023 | 644 |
| Nov 2023 | 644 |
| Dec 2023 | 644 |
| Jan 2024 | 644 |
| Feb 2024 | 644 |
| Mar 2024 | 644 |
| Apr 2024 | 644 |
| May 2024 | 644 |
| Jun 2024 | 644 |
| Jul 2024 | 644 |
CAMP4 Therapeutics other data
29.59%
-43.17%
of CAMP is owned by hedge funds
43
-48
10.69M
-15.76M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 0 | 8640 |
| Patent |
|---|
Application Filling date: 27 May 2022 Issue date: 8 Sep 2022 |
Grant Filling date: 23 Mar 2020 Issue date: 6 Sep 2022 |
Application Filling date: 30 Nov 2021 Issue date: 25 Aug 2022 |
Application Filling date: 5 Apr 2022 Issue date: 11 Aug 2022 |
Grant Filling date: 26 Aug 2019 Issue date: 12 Jul 2022 |
Grant Filling date: 13 May 2020 Issue date: 5 Jul 2022 |
Application Filling date: 18 Mar 2022 Issue date: 30 Jun 2022 |
Grant Utility: Systems and methods for automatic threshold sensing for UVLO circuits in a multi-battery environment Filling date: 20 Jan 2021 Issue date: 17 May 2022 |
Application Filling date: 21 Dec 2021 Issue date: 14 Apr 2022 |
Grant Filling date: 26 May 2020 Issue date: 5 Apr 2022 |
| Quarter | Transcript |
|---|---|
| Q3 2024 9 Jan 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 5 Oct 2023 | Q2 2024 Earnings Call Transcript |
| Q1 2024 10 Jul 2023 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Apr 2023 | Q4 2023 Earnings Call Transcript |
-
What's the price of CAMP4 Therapeutics stock today?
One share of CAMP4 Therapeutics stock can currently be purchased for approximately $1.7.
-
When is CAMP4 Therapeutics's next earnings date?
Unfortunately, CAMP4 Therapeutics's (CAMP) next earnings date is currently unknown.
-
Does CAMP4 Therapeutics pay dividends?
No, CAMP4 Therapeutics does not pay dividends.
-
How much money does CAMP4 Therapeutics make?
CAMP4 Therapeutics has a market capitalization of 110.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.3% to 294.95M US dollars.
-
What is CAMP4 Therapeutics's stock symbol?
CAMP4 Therapeutics Corporation is traded on the NASDAQ under the ticker symbol "CAMP".
-
What is CAMP4 Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of CAMP4 Therapeutics?
Shares of CAMP4 Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are CAMP4 Therapeutics's key executives?
CAMP4 Therapeutics's management team includes the following people:
- Mr. Jeffery R. Gardner Pres, Chief Executive Officer & Director(age: 65, pay: $1,710,000)
- Mr. Arym Diamond Senior Vice President & Chief Revenue Officer(age: 46, pay: $722,330)
- Mr. Kurtis Joseph Binder Executive Vice President, Chief Financial Officer & Principal Accounting Officer(age: 55, pay: $672,690)
- Mr. Anand Rau Senior Vice President & Chief Technology Officer(age: 62, pay: $477,350)
-
How many employees does CAMP4 Therapeutics have?
As Jul 2024, CAMP4 Therapeutics employs 644 workers.
-
When CAMP4 Therapeutics went public?
CAMP4 Therapeutics Corporation is publicly traded company for less than a year since IPO on 11 Oct 2024.
-
What is CAMP4 Therapeutics's official website?
The official website for CAMP4 Therapeutics is camp4tx.com.
-
Where are CAMP4 Therapeutics's headquarters?
CAMP4 Therapeutics is headquartered at One Kendall Square Bldg 1400 West, 3rd Floor, Cambridge, MA.
-
How can i contact CAMP4 Therapeutics?
CAMP4 Therapeutics's mailing address is One Kendall Square Bldg 1400 West, 3rd Floor, Cambridge, MA and company can be reached via phone at +61 76518867.
-
What is CAMP4 Therapeutics stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for CAMP4 Therapeutics in the last 12 months, the avarage price target is $17.5. The average price target represents a 929.41% change from the last price of $1.7.
CAMP4 Therapeutics company profile:
CAMP4 Therapeutics Corporation
camp4tx.comExchange:
NASDAQ
Full time employees:
58
Industry:
Biotechnology
Sector:
Healthcare
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
One Kendall Square Bldg 1400 West, 3rd Floor
Cambridge, MA 02139
Cambridge, MA 02139
CIK: 0001736730
ISIN: US13463J1016
CUSIP: 13463J101
